您的位置: 首页 > 2016年3月 第47卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

耐碳青霉烯肠杆菌科细菌的流行特征研究

Epidemiological features of carbapenem resistant Enterobacteriaceae

来源期刊: 广州医药 | 10-13 发布时间:2021-11-30 收稿时间:2025/11/13 17:02:45 阅读量:13
作者:
关键词:
碳青霉烯耐药肠杆菌科细菌流行特征分析
Carbapenem resistanceEnterobacteriaceaeEpidemiological features
DOI:
10.3969/j.issn.1000-8535.2016.02.004
收稿时间:
2015-12-09 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 统计分析2011—2014年我院分离的肠杆菌科细菌数据,探讨耐碳青霉烯肠杆菌科细菌(CRE)的流行特征。方法 收集肠杆菌科细菌,根据药敏结果筛选出CRE菌株,并对相关临床资料进行统计分析。结果 共分离得到CRE菌株187株,标本来源依次为尿液(32.6%)、痰液(28.9%)和血液(10.7%)。从科室分布来看,39.0%的菌株来自重症监护室病区,23.0%的菌株来自泌尿外科病区,在其它病区呈散发分布。菌株的种属分布方面,肺炎克雷伯菌的比例为39.6%, 大肠埃希菌的比例为20.9%;从病人年龄构成来看,50岁以上高龄患者的分离比例达74.4%。CRE的分离数目随年份的递增而不断升高。结论 耐碳青霉烯肠杆菌科细菌的流行率呈现逐年递增的趋势,临床应合理使用相关抗生素,预防和控制CRE在医院环境中的流行。
Objective To investigate the epidemiological features of carbapenem resistant Enterobacteriaceae in a collection of clinical Enterobacteriaceae strains isolated during 2011-2014 from our hospital. Methods The Enterobacteriaceae strains were collected and CRE strains were screened by their resistance to carbapenems. Clinical information was analyzed to characterize the epidemiological traits of CRE strains. Results The total number of CRE isolates was 187. These CRE strains were isolated from various clinical specimens, including urine(32.6%), sputum (28.9%), blood (10.7%), and so on. These strains were frequently isolated from intensive care units (ICU) (39.0%) and department of Urology (23.0%). The most frequently isolated species were Klebsiella pneumoniae (39.6%), Escherichia coli (20.9%). The isolation rate is much higher in elderly patients more than 50 years old (74.4%). The percentage of CRE isolates were kept on increasing by years. Conclusion The prevalence carbapenem resistant Enterobacteriaceae in our hospital is increasing every year and it is important to prevent and control the transmission and outbreaks of CRE in the hospital by proper use of related antibiotics in clinical treatment.
1、 OTEO J, SAEZ D, BAUTISTA V, et al. Carbapenemase-producing Enterobacteriaceae in Spain in 2012 [J].Antimicrob Agents Chemother, 2013, 57 (12): 6344-6347. OTEO J, SAEZ D, BAUTISTA V, et al. Carbapenemase-producing Enterobacteriaceae in Spain in 2012 [J].Antimicrob Agents Chemother, 2013, 57 (12): 6344-6347.
2、 VAN DUIN D, KAYE KS, NEUNER EA, et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes [J].Diagn Microbiol Infect Dis, 2013, 75 (2):115-120. VAN DUIN D, KAYE KS, NEUNER EA, et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes [J].Diagn Microbiol Infect Dis, 2013, 75 (2):115-120.
3、 DORTET L, POIREL L, NORDMANN P. Rapid Detection of ESBL-Producing Enterobacteriaceae in Blood Cultures [J].Emerg Infect Dis, 2015, 21(3): 504-507. DORTET L, POIREL L, NORDMANN P. Rapid Detection of ESBL-Producing Enterobacteriaceae in Blood Cultures [J].Emerg Infect Dis, 2015, 21(3): 504-507.
4、 WEIMEI O, LANQING C, YUN L, et al. Epidemiological Characteristics of blaNDM-1 in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex in China from 2011 to 2012 [J].PLoS One, 2014, 9 (12): e113852. WEIMEI O, LANQING C, YUN L, et al. Epidemiological Characteristics of blaNDM-1 in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex in China from 2011 to 2012 [J].PLoS One, 2014, 9 (12): e113852.
5、 NORDMANN P, NAAS T, POIREL L. Global spread of Carbapenemase-producing Enterobacteriaceae [J].Emerg Infect Dis, 2011, 17 (10):1791-1798. NORDMANN P, NAAS T, POIREL L. Global spread of Carbapenemase-producing Enterobacteriaceae [J].Emerg Infect Dis, 2011, 17 (10):1791-1798.
6、 GARCIA-FERNANDEZ A, VILLA L, CARTA C, et al. Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants [J].Antimicrob Agents Chemother, 2012,56 (4):2143-2145. GARCIA-FERNANDEZ A, VILLA L, CARTA C, et al. Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants [J].Antimicrob Agents Chemother, 2012,56 (4):2143-2145.
7、 LIU Y, WAN LG, DENG Q, et al. First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital [J].Epidemiol Infect, 2014, 143 (2):376-384. LIU Y, WAN LG, DENG Q, et al. First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital [J].Epidemiol Infect, 2014, 143 (2):376-384.
8、 MARSIK FJ, NAMBIAR S. Review of carbapenemases and AmpC-beta lactamases [J].Pediatr Infect Dis J, 2011, 30 (12):1094-1095. MARSIK FJ, NAMBIAR S. Review of carbapenemases and AmpC-beta lactamases [J].Pediatr Infect Dis J, 2011, 30 (12):1094-1095.
9、 PAPP-WALLACE KM, ENDIMIANI A, TARACILA MA, et al. Carbapenems: past, present, and future[J].Antimicrob Agents Chemother, 2011, 55(11):4943-4960. PAPP-WALLACE KM, ENDIMIANI A, TARACILA MA, et al. Carbapenems: past, present, and future[J].Antimicrob Agents Chemother, 2011, 55(11):4943-4960.
10、 LOGAN LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children[J].Clin Infect Dis, 2012, 55 (6):852-859. LOGAN LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children[J].Clin Infect Dis, 2012, 55 (6):852-859.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录